We use cookies to collect anonymous data to help us improve your site browsing experience.

Click 'Accept all cookies' to agree to all cookies that collect anonymous data. To only allow the cookies that make the site work, click 'Use essential cookies only.' Visit 'Set cookie preferences' to control specific cookies.

Set cookie preferences

Your cookie preferences have been saved. You can change your cookie settings at any time.

Publication - Advice and guidance

Brain and central nervous system cancer: clinical quality performance indicators - engagement document

Published
22 January 2024
From
Chief Operating Officer and Deputy Chief Executive, NHS Scotland
Directorate
Chief Operating Officer, NHS Scotland Directorate
Topic
Health and social care
ISBN
9781835219140

Guidance to our consultation on brain and central nervous system cancer clinical quality performance indicators which is taking place in January and February 2024.

View supporting documents Supporting documents

2. Quality Performance Indicator (QPI) Development Process

The QPI development process was designed to ensure that indicators are developed in an open, transparent and timely way.

The Brain/Central Nervous System (CNS) Cancer QPI Development Group was convened in May 2012, chaired by Dr Hilary Dobson, Deputy Director, Innovative Healthcare Delivery Programme. Membership of this group included representatives drawn from the three regional cancer networks, Healthcare Improvement Scotland, Information Services Division (ISD) and patient/carer representatives.

The development process and membership of the development group can be found in appendix 1.

Contact

Email: cancerpolicyteam@gov.scot

Back to top